In addition, Yin et al. (2018) observed an increase of NLRP3 inflammasome in TgCRND8 mice, a mouse model of AD, inhibited by the treatment with JC‐124, a small molecule that harm NLRP3 oligomerization. Here, NLRP3 is linked to Alzheimer disease.